GLI1-activated tumours constitute a distinct subclass of soft tissue neoplasm. Due to their rarity, the clinical course and treatment options for these neoplasms are not well understood.
Dowavic et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: